Chemists have developed a revolutionary new way to manufacture natural chemicals by clipping smaller molecules together like Lego. They have used the new method to assemble a scarce anti-inflammatory drug with potential to treat cancer and malaria, pseudopterosin.
“We took small molecules and clipped them together like Lego,” said lead researcher Professor Michael Sherburn, from the Research School of Chemistry.
“The building blocks are carefully designed in such a way that the first reaction generates a product perfectly primed for the second. It’s quite magical. This means you can efficiently build large and complex molecules.”
Medicines of this type have traditionally been made in a cumbersome way. Chemists take a related molecule and renovate it. This is a lengthy process, with unwanted structural features being ripped out and replaced.
“This leads to a lot of waste,” Professor Sherburn said.
The group trialed their innovative new method by making pseudopterosin, a powerful anti-inflammatory and analgesic drug, which is currently only available in tiny quantities extracted from fan coral found in the Bahamas.
The work began as blue-sky research, with the researchers trying to work out a way to make supposedly impossible molecules of cross-conjugated hydrocarbons.
Before trying the experiments the team ran simulations on the Raijin supercomputer, which indicated that their method had potential.
“Ours is an empowering and enabling technique, allowing a smarter and faster way to make important substances,” said Dr Chris Newton, who did the research in the laboratory as a PhD student.
The Latest on: Manufacturing new drugs
via Google News
The Latest on: Manufacturing new drugs
- New technology enables fast protein synthesison May 28, 2020 at 11:02 am
Many proteins are useful as drugs for disorders such as diabetes, cancer, and arthritis. Synthesizing artificial versions of these proteins is a time-consuming process that requires genetically ...
- Trump administration signs up new company to make COVID-19 drugs in U.S.on May 28, 2020 at 10:32 am
The administration has been looking to build up the ability to produce drugs and their raw materials in the United States after the global pandemic exposed the industry's dependence on China and India ...
- Moscow Raises Death Toll; Gilead, Roche Pair Drugs: Virus Updateon May 28, 2020 at 8:15 am
South Korea reported its biggest spike in new coronavirus cases in almost two months, raising concern about a second wave of infections. Small clusters also emerged in several locations in Japan in ...
- Myocardial Infarction Drugs Market to Witness Huge Growth by 2026 | AstraZeneca, Bayer HealthCare, Eli Lilly, Novartison May 28, 2020 at 4:43 am
HTF MI Analyst have added a new research study on Title Myocardial Infarction Drugs Market Research: Global Status & Forecast by Geography, Type & Application (2016-2026) with detailed information of ...
- PHAS To Begin COVID-19 Drug Trial In June, MRSN Hits New High, LJPC Plunges, RCUS On Watchon May 27, 2020 at 10:41 pm
Today's Daily Dose brings you news about NantKwest teaming up with ImmunityBio to accelerate the development of vaccines and therapeutics for COVID-19; Mersana's promising data in ovarian cancer and ...
- Trump Wants To Bring Drug Manufacturing Back To United States. Pharma, Not So Much.on May 26, 2020 at 9:48 pm
Read about the biggest pharmaceutical development and pricing stories from the past week in KHN’s Prescription Drug Watch roundup.
- Trump Signs Deal With Company in Effort Shift Drug Manufacturing to U.S.: New York Timeson May 20, 2020 at 8:23 am
U.S. President Donald Trump's administration awarded a contract worth up to $812 million for a new U.S. company to manufacture drugs and drug ingredients to fight COVID-19 on American soil, aiming to ...
- Trump Admin Awards New Contract to Bring Drug Manufacturing Back to USon May 19, 2020 at 4:06 pm
The Trump administration said Tuesday that it has awarded a $354 million contract for a private sector team led by a Virginia-based startup called Phlow Corp. to make generic drugs and their ...
- Drug manufacturing must be brought to UK, NHS bosses and charities tell MPson May 9, 2020 at 11:07 pm
where you have the ability and the manufacturing capacity to make critical drugs in the UK,” he told MPs. Drug shortages are not new, and are a global problem. The Medicines and Healthcare ...
- Outsourcing U.S. Drug Manufacturing to China was a Mistake—A Lethal One | Opinionon May 5, 2020 at 10:04 am
The U.S. Government and private industry need to immediately recognize this problem and join together to create a new plan to build and protect manufacturing ... most of our drugs come from.
via Bing News